相关实验视频
Updated: May 22, 2025

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.1K
聚合分子过敏剂Alt a1:在儿童喘患者中有效的SCIT
Giulia Brindisi1, Alessandra Gori1, Caterina Anania1
1Department of Mother-Child, Urological Science, La Sapienza University, 00161 Rome, Italy.
Journal of clinical medicine
|March 17, 2025
概括
使用聚合Alternaria alternata (Alt a1) 的皮下免疫疗法 (SCIT) 在患有过敏性鼻炎和喘的儿童中显著改善了肺功能和喘控制. 这种新的治疗方法可以防止过敏疾病的进展.
科学领域:
- 过敏学和免疫学
- 儿科呼吸系统医学 儿科呼吸系统医学
背景情况:
- 另类 (Alt a) 过敏是一种严重的,往往被误诊的全球健康问题.
- 新型聚合过敏药正在成为过敏原免疫疗法 (AIT) 的先进选择.
研究的目的:
- 在患有呼吸道过敏的儿童中,评估使用新型聚合分子过敏体 (Alt a1) 的皮下免疫疗法 (SCIT) 的疗效.
- 评估过敏性鼻炎和喘儿童的临床和功能参数,这些儿童对Alt a.具有单一敏感性.
主要方法:
- 一项涉及42名 (6-16岁) 患有过敏性鼻炎和喘的儿童的研究,对Alt a.单一敏感.
- 将SCIT与Alt a1 (Modigoid®) 与24个月的标准治疗进行比较,包括螺旋计,呼出的氧化 (eFeNO) 和喘控制测试 (ACT) 的评估.
主要成果:
- 使用Alt a1的SCIT在24个月后显示了eFeNO水平的统计显著降低.
- 在SCIT组中观察到FEV1值和ACT得分的显著改善.
- 该研究强调了这种新型SCIT方法在儿科患者中的有效性.
结论:
- 使用新的分子过敏剂Alt a1的SCIT有效地提高了儿童的功能参数 (FEV1,eFeNO) 和喘症状控制 (ACT分数).
- 这种治疗可以作为一种潜在的预防策略,防止从过敏性鼻炎到喘的亚托皮性进展.
- 这些发现表明,Alt a1 SCIT可以阻止或潜在地逆转过敏呼吸道疾病的进展.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
206
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
206
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
185
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
185
Antiasthma Drugs: Leukotriene Modifiers
213
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
213
Allergic Reactions
27.2K
Overview
27.2K
Adrenergic Agonists: Therapeutic Uses
707
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
707

